Connor, Clark & Lunn Investment Management (CC&L)’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,713	Closed	-$43K	–	1051
2016 Q3	$43K	Sell	1,713 -5,508	-76%	-$139K	﹤0.01%	806
2016 Q2	$178K	Sell	7,221 -7,278	-50%	-$206K	﹤0.01%	756
2016 Q1	$420K	Sell	14,499 -1,275	-8%	-$34.6K	﹤0.01%	597
2015 Q4	$586K	Buy	15,774 +575	+4%	+$25.4K	﹤0.01%	520
2015 Q3	$740K	Sell	15,199 -3,564	-19%	-$249K	0.01%	454
2015 Q2	$1.29M	Buy	18,763 +3,525	+23%	+$163K	0.01%	298
2015 Q1	$545K	Buy	+15,238	New	+$451K	﹤0.01%	383

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s ANTH Position: Q4 2016 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2016, closing a stake of 1,713 shares — an estimated $43K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ANTH in Q1 2015 and held it in 7 quarters. The position peaked at $1.29M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 1,713 Anthera Pharmaceuticals, Inc. shares in Q4 2016, an estimated $43K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Anthera Pharmaceuticals, Inc. position peaked at $1.29M in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2016, filed 13 Feb 2017.